Milestone Scientific Inc (NYSE:MLSS). (NYSE:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, said it has added three new international distributors for the CompuFlo Epidural Instrument, including Andau Medical in Canada, Sanolabor DD in Slovenia, and New Al Farwaniya Surgicals and Medical Equipment LLC in the United Arab Emirates (UAE).
“The CompuFlo Epidural Instrument is an important and revolutionary advancement that will significantly improve women’s health during one of the most pivotal moments in life, the birth of a child,” Andau Medical CEO Sandi Wright said in a statement.
“Our collaboration with Milestone Scientific to bring this technology to Canada is a critical step towards providing all women with access to pain relief during labor that is safe, with a decreased risk of side effects. The CompuFlo Epidural Instrument not only improves patient outcomes but also decreases overall cost to the health system.”
READ: Milestone Scientific approved to supply its CompuFlo Epidural and CathCheck Verification System disposables across Florida
Milestone Scientific CEO Arjan Haverhals said the company is “pleased” to have expanded its international network with distributors in key global markets.
“Each brings extensive relationships and a proven track record of introducing medical devices to their respective markets. The global network we are developing demonstrates the strong interest and growing demand for the CompuFlo Epidural Instrument,” added Haverhals. “Andau Medical, Sanolabor and New Al Farwaniya are important additions, and assist in further adoption of our epidural instrument.”
In addition, Milestone said it has seen increased usage at the University Hospital of Würzburg, in Germany which has created “a strong case” for expansion activities in Europe.
“We look forward to advancing our commercialization efforts around the world, as we aim to establish the CompuFlo Epidural Instrument as the new standard of care,” said Haverhals.
Meanwhile, Dr. Abraham Scheer who has over 40 years of clinical experience as a neuro-hospitalist, said he has seen too many cases of inadvertent epidural needle placement resulting in complications.
“I have known for many years the dural puncture rate is much higher,” said Dr. Scheer. “This FDA approved computer-assisted technology can drastically reduce or eliminate the majority of the complications such that success rates, patient satisfaction, and patient safety are improved, while iatrogenic injury and potential liability are decreased.”
The CompuFlo Epidural Instrument offers objective detection of pressure changes to verify true loss of resistance and confirm epidural space within minutes. The clinical and safety benefits of the CompuFlo Epidural and CathCheck Verification Systems are backed by extensive clinical data demonstrating significant reductions in epidural punctures and complications.
Milestone designs and patents innovative injection technology and specializes in dynamic pressure sensing, which allows medics and anesthesiologists to know what the pressure at the tip of the needle is at any given time.
Contact the author Uttara Choudhury at uttara@proactiveinvestors.com
Follow her on Twitter: @UttaraProactive